{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:31:52Z","timestamp":1791250312810,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2562,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/ki.2008.358","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T08:11:36Z","timestamp":1216800696000},"page":"1379-1384","source":"Crossref","is-referenced-by-count":85,"title":["Role of angiotensin II AT1 receptor activation in cardiovascular diseases"],"prefix":"10.1016","volume":"74","author":[{"given":"Sandrine","family":"Billet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9derick","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Baudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Clauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.358_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1524-6175.2007.5998.x","article-title":"Hypertension treatment guidelines: is it time for an update?","volume":"9","author":"Moser","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1038\/ki.2008.358_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1038\/ki.2008.358_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1043-2760(02)00628-8","article-title":"Lessons from constitutively active mutants of G protein-coupled receptors","volume":"13","author":"Parnot","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/ki.2008.358_bb0025","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1073\/pnas.110142297","article-title":"Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay","volume":"97","author":"Parnot","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0030","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI28764","article-title":"Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice","volume":"117","author":"Billet","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.358_bb0035","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.358_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tem.2005.02.009","article-title":"Genetics of human hypertension","volume":"16","author":"Agarwal","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/ki.2008.358_bb0050","first-page":"611","article-title":"Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma","volume":"82","author":"Davies","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2008.358_bb0055","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.92.7.2735","article-title":"Genetic control of blood pressure and the angiotensinogen locus","volume":"92","author":"Kim","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.HYP.0000092000.07559.57","article-title":"Physiological impact of increased expression of the AT1 angiotensin receptor","volume":"42","author":"Le","year":"2003","journal-title":"Hypertension"},{"key":"10.1038\/ki.2008.358_bb0065","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.87.13.5153","article-title":"Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes","volume":"87","author":"Ohkubo","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1043-2760(00)00279-4","article-title":"Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting","volume":"11","author":"Audoly","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/ki.2008.358_bb0075","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature"},{"key":"10.1038\/ki.2008.358_bb0080","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0085","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/01.CIR.97.19.1952","article-title":"Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice","volume":"97","author":"Harada","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0090","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"Wassmann","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0100","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0602715103","article-title":"Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response","volume":"103","author":"Ramchandran","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0105","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/ki.2008.358_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.358_bb0115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1038\/ki.2008.358_bb0120","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1161\/hc4601.099401","article-title":"Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor","volume":"104","author":"Brede","year":"2001","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2007.01775.x","article-title":"Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study","volume":"261","author":"Mortsell","year":"2007","journal-title":"J Intern Med"},{"key":"10.1038\/ki.2008.358_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.CIR.0000024103.04821.86","article-title":"Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0135","series-title":"Renin\u2013Angiotensin Inhibitors and Vascular Effects","author":"Schffrin","year":"2004"},{"issue":"Suppl 1","key":"10.1038\/ki.2008.358_bb0140","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00005344-200312001-00014","article-title":"Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts","volume":"42","author":"Tokuda","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/ki.2008.358_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1038\/ki.2008.358_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.358_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.ATV.0000193625.32499.71","article-title":"Role of blood cell-associated AT1 receptors in the microvascular responses to hypercholesterolemia","volume":"26","author":"Petnehazy","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2008.358_bb0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/ndt\/gfh030","article-title":"Renin-angiotensin system and atherosclerosis","volume":"19","author":"Grote","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.358_bb0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.358_bb0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jcp.1079","article-title":"Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction","volume":"187","author":"Staufenberger","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1038\/ki.2008.358_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.97.4.315","article-title":"Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias","volume":"97","author":"Harada","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.358_bb0180","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/HYPERTENSIONAHA.106.075085","article-title":"Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look","volume":"49","author":"Reudelhuber","year":"2007","journal-title":"Hypertension"},{"key":"10.1038\/ki.2008.358_bb0185","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1073\/pnas.94.12.6391","article-title":"Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block","volume":"94","author":"Hein","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.358_bb0190","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1038\/ki.2008.358_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/hh0202.104109","article-title":"Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor","volume":"90","author":"Thomas","year":"2002","journal-title":"Circ Res"},{"key":"10.1038\/ki.2008.358_bb0200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.358_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.35.1.273","article-title":"Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts","volume":"35","author":"Kawano","year":"2000","journal-title":"Hypertension"},{"key":"10.1038\/ki.2008.358_bb0210","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1253\/circj.71.524","article-title":"Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients\u2014reversal by chronic angiotensin II type 1A receptor blockade","volume":"71","author":"Kawasaki","year":"2007","journal-title":"Circ J"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:39:10Z","timestamp":1738280350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815532018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0085253815532018"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.358","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}